Table 1 Patients’ demographics (n = 86)
From: Index of deterioration of patients with mechanical prosthetic heart valve thrombosis
Variable | |
|---|---|
Age (years) | 40 (16-74) |
Female gender | 52 (60.5%) |
Pregnancy | 16 (18.6%) |
Number of implanted prostheses | 91 |
Mechanical bileaflet | 85 (93.4%) |
Mechanical mono-leaflet | 4 (4.4%) |
Additional tricuspid bioprosthesis* | 2 (2.2%) |
Position of implantation | |
Mitral | 68 (79.1%) |
Aortic | 13 (15.1%) |
Mitral and aortic | 3 (3.5%) |
Mitral + tricuspid bioprosthesis* | 2 (2.3%) |
Non-compliance to OAC | 53 (61.6%) |
Main presenting symptom: | |
Dyspnea and palpitation | 70 (81.4%) |
Thromboembolic event | 12 (14%) |
Threatened abortion | 4 (4.6%) |
NYHA class at presentation | |
Class IV | 47 (54.7%) |
Class III | 36 (41.9%) |
Class II | 3 (3.5%) |
Numerical NYHA class | 3.5 (2-4) |
LVEF% | 57.5 (22-73) |
Mean pressure gradient across mitral prosthesis (mm Hg) | 12 (9-20) |
Mean pressure gradient across aortic prosthesis (mm Hg) | 54 (5-80) |
INR on admission | 1.55 (0.7-4.2) |
Serum creatinine (mg/dl) | 1.37 (0.6-4.2) |
SGOT (units/liter) | 45 (15-150) |
Latent period** (months) | 44.6 (0.77-365) |
Index of deterioration (ID) | 0.43 (0.03-3) |
EuroScore II | 6.75 (1.69-26.5) |